Search Results

Your search for Francis Paul Worden, MD,Francis Paul Worden, MD matches 2 pages

Showing 1 - 2

By Francis Paul Worden, MD, and Michelle Lynn Mierzwa, MD / August 10, 2021

JAVELIN Head and Neck 100 Trial: When Failure Seems Fatal, Hope Is Not Lost

Data from KEYNOTE-048 showed that the combination of the checkpoint inhibitor pembrolizumab with platinum-containing therapy improved overall survival vs cetuximab plus chemotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).1 The findings provided hope...

solid tumors

head and neck cancer

By Francis Paul Worden, MD / February 25, 2018

Laryngeal Preservation: All Patients Need a Voice

Following the publication of two landmark studies in the United States,1,2 laryngeal preservation with combined chemoradiotherapy has become standard practice as opposed to laryngectomy for patients with locally advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study...

May

Today In Oncology

Search Results

Your search for Francis Paul Worden, MD,Francis Paul Worden, MD matches 2 pages

JAVELIN Head and Neck 100 Trial: When Failure Seems Fatal, Hope Is Not Lost

Laryngeal Preservation: All Patients Need a Voice

Glecirasib Shows Efficacy and Safety in KRAS G12C–Mutated NSCLC

Metastatic Castration-Resistant Prostate Cancer Addition of LuPSMA to Enzalutamide

Breast Implant–Related Cancers: Should Our Patients Be Concerned?

Pediatric AML Comparison of Induction Regimens

Older Patients With Newly Diagnosed Hodgkin Lymphoma Preexisting Heart Failure and Survival Outcomes